Avidity Biosciences, Inc. financial data

Symbol
RNA on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 23 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1102% % -29%
Debt-to-equity 14% % 29%
Return On Equity -45% % -74%
Return On Assets -40% % -69%
Operating Margin -3977% % -14%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 155,149,646 shares 29%
Common Stock, Shares, Outstanding 151,205,000 shares 26%
Entity Public Float $3,400,000,000 USD -23%
Common Stock, Value, Issued $15,000 USD 25%
Weighted Average Number of Shares Outstanding, Basic 137,710,000 shares 23%
Weighted Average Number of Shares Outstanding, Diluted 137,710,000 shares 23%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $18,755,000 USD 72%
Research and Development Expense $559,159,000 USD 84%
General and Administrative Expense $205,539,000 USD 138%
Operating Income (Loss) $745,943,000 USD -97%
Nonoperating Income (Expense) $61,312,000 USD 8.3%
Net Income (Loss) Attributable to Parent $684,631,000 USD -112%
Earnings Per Share, Basic -4.97 USD/shares -72%
Earnings Per Share, Diluted -4.97 USD/shares -72%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $382,517,000 USD 74%
Cash, Cash Equivalents, and Short-term Investments $1,200,000,000 USD -7.7%
Accounts Receivable, after Allowance for Credit Loss, Current $0 USD -100%
Other Assets, Current $52,703,000 USD 181%
Assets, Current $1,798,467,000 USD 17%
Property, Plant and Equipment, Net $23,333,000 USD 84%
Operating Lease, Right-of-Use Asset $51,278,000 USD 813%
Other Assets, Noncurrent $82,175,000 USD 15673%
Assets $1,958,050,000 USD 25%
Accounts Payable, Current $12,403,000 USD 47%
Contract with Customer, Liability, Current $21,639,000 USD 3.1%
Liabilities, Current $195,446,000 USD 99%
Contract with Customer, Liability, Noncurrent $28,691,000 USD -24%
Operating Lease, Liability, Noncurrent $45,313,000 USD 1432%
Liabilities $269,450,000 USD 94%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,562,000 USD -12%
Retained Earnings (Accumulated Deficit) $1,577,697,000 USD -77%
Stockholders' Equity Attributable to Parent $1,688,600,000 USD 19%
Liabilities and Equity $1,958,050,000 USD 25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $124,829,000 USD -77%
Net Cash Provided by (Used in) Financing Activities $1,937,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $157,188,000 USD
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 151,205,000 shares 26%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $34,335,000 USD -88%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $385,314,000 USD 73%
Deferred Tax Assets, Valuation Allowance $490,371,000 USD 81%
Deferred Tax Assets, Gross $501,164,000 USD 84%
Operating Lease, Liability $49,251,000 USD 624%
Depreciation $4,151,000 USD 50%
Payments to Acquire Property, Plant, and Equipment $3,753,000 USD 310%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $684,971,000 USD -114%
Lessee, Operating Lease, Liability, to be Paid $81,680,000 USD 990%
Property, Plant and Equipment, Gross $35,114,000 USD 70%
Operating Lease, Liability, Current $3,938,000 USD 2.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,259,000 USD 99%
Lessee, Operating Lease, Liability, to be Paid, Year One $8,323,000 USD 116%
Operating Lease, Weighted Average Discount Rate, Percent 0.114 pure 93%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $32,429,000 USD 4586%
Lessee, Operating Lease, Liability, to be Paid, Year Three $9,230,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $156,263,000 USD 87%
Unrecognized Tax Benefits $37,188,000 USD 68%
Lessee, Operating Lease, Liability, to be Paid, Year Four $9,506,000 USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $10,793,000 USD 804%
Share-based Payment Arrangement, Expense $97,838,000 USD 90%